Liberty Star Uranium & Metals (LBSR) 10-Q 10 Sep 20 2021 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jul. 31, 2020	Sep. 10, 2020
Cover [Abstract]
Entity Registrant Name	LIBERTY STAR URANIUM & METALS CORP.
Entity Central Index Key	0001172178
Document Type	10-Q
Document Period End Date	Jul. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--01-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		4,949,822,059
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2021

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jul. 31, 2020	Jan. 31, 2020
Current:
Cash and cash equivalents	$ 9,487	$ 25,024
Prepaid expenses	9,488	8,311
Total current assets	18,975	33,335
Property and equipment, net	36,545	39,892
Total assets	55,520	73,227
Current:
Accounts payable and accrued liabilities	463,027	458,350
Accounts payable to related parties	51,119	51,119
Accrued wages to related parties	811,711	811,711
Advances from related party	177,058	101,631
Notes payable to related parties	206,188	166,560
Convertible promissory note, net of debt discount of $0 and $15,364		152,504
Total current liabilities	1,709,103	1,741,875
Long-term:
Long-term accounts payable, net of current portion	29,300	37,400
Long-term debt	62,974
Total long-term liabilities	92,274	37,400
Total liabilities	1,801,377	1,779,275
Commitments and Contingencies (Note 10)
Stockholders' deficit
Common stock value	49,498	45,584
Additional paid-in capital	55,493,492	55,028,764
Accumulated deficit	(57,289,357)	(56,780,396)
Total stockholders' deficit	(1,745,857)	(1,706,048)
Total liabilities and stockholders' deficit	55,520	73,227
Class A Common Stock [Member]
Stockholders' deficit
Common stock value	$ 510

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Jul. 31, 2020	Jan. 31, 2020
Convertible promissory note, debt discount	$ 0	$ 15,364
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	6,150,000,000	6,250,000,000
Common stock, shares issued	4,949,822,059	4,558,362,693
Common stock, shares outstanding	4,949,822,059	4,558,362,693
Class A Common Stock [Member]
Common stock, par value	$ .00001	$ .00001
Common stock, shares authorized	100,000,000	0
Common stock, shares issued	51,000,000	0
Common stock, shares outstanding	51,000,000	0

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Income Statement [Abstract]
Revenues
Expenses:
Geological and geophysical costs	51,593	1,380	54,551	1,980
Salaries and benefits	33,971	82,495	71,721	117,984
Public relations		500		500
Depreciation	1,673	277	3,347	770
Legal	44,936	1,475	95,472	1,475
Professional services	23,477	24,439	43,433	49,223
General and administrative	13,704	13,233	33,665	27,626
Travel			439
Net operating expenses	169,354	123,799	302,628	199,558
Loss from operations	(169,354)	(123,799)	(302,628)	(199,558)
Other income (expense):
Interest expense	(61,199)	(6,992)	(166,702)	(39,603)
Gain on settlement of accounts payable		177,000		177,000
Loss on change in fair value of derivative liability	(94,667)		(39,631)	(4,462)
Total other income (expense)	(155,866)	170,008	(206,333)	132,935
Net income (loss)	$ (325,220)	$ 46,209	$ (508,961)	$ (66,623)
Net income (loss) per share of common stock - basic and diluted	$ 0	$ 0	$ 0	$ 0
Weighted average number of shares of common stock outstanding - basic and diluted	4,884,803,115	4,312,482,505	4,744,208,265	4,274,369,853

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Class A Common Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Beginning Balance at Jan. 31, 2019		$ 40,975	$ 54,708,186	$ (56,442,927)	$ (1,693,766)
Beginning Balance, shares at Jan. 31, 2019		4,097,457,393
Issuance of common stock and warrants in private placement		$ 432	49,568		50,000
Issuance of common stock and warrants in private placement, shares		43,215,212
Shares issued for conversion of notes		$ 1,974	19,740		21,714
Shares issued for conversion of notes, shares		197,400,727
Settlement of accounts payable through issuance of common stock		$ 300	35,700		36,000
Settlement of accounts payable through issuance of common stock, shares		30,000,000
Resolution of derivative liabilities due to debt conversions and untainted warrants			63,118		63,118
Stock based compensation			60,670		60,670
Net loss				(66,623)	(66,623)
Ending Balance at Jul. 31, 2019		$ 43,681	54,936,982	(56,509,550)	(1,528,887)
Ending Balance, shares at Jul. 31, 2019		4,368,073,332
Beginning Balance at Apr. 30, 2019		$ 42,949	54,791,044	(56,555,759)	(1,721,766)
Beginning Balance, shares at Apr. 30, 2019		4,294,858,120
Issuance of common stock and warrants in private placement		$ 432	49,568		50,000
Issuance of common stock and warrants in private placement, shares		43,215,212
Settlement of accounts payable through issuance of common stock		$ 300	35,700		36,000
Settlement of accounts payable through issuance of common stock, shares		30,000,000
Stock based compensation			60,670		60,670
Net loss				46,209	46,209
Ending Balance at Jul. 31, 2019		$ 43,681	54,936,982	(56,509,550)	(1,528,887)
Ending Balance, shares at Jul. 31, 2019		4,368,073,332
Beginning Balance at Jan. 31, 2020		$ 45,584	55,028,764	(56,780,396)	(1,706,048)
Beginning Balance, shares at Jan. 31, 2020		4,558,362,693
Issuance of common stock and warrants in private placement		$ 270	20,329		20,599
Issuance of common stock and warrants in private placement, shares		27,000,000
Shares issued for conversion of notes		$ 2,930	166,930		169,860
Shares issued for conversion of notes, shares		293,030,795
Resolution of derivative liabilities due to debt conversions and untainted warrants			369,103		369,103
Reclass of APIC to derivative liabilities for tainted warrants			(189,472)		(189,472)
Class A Shares issued to settle related party advances and notes payable	$ 510		48,552		49,062
Class A Shares issued to settle related party advances and notes payable, shares	51,000,000
Shares issued for services		$ 714	49,286		$ 50,000
Shares issued for services, shares		71,428,571			71,428,571
Net loss				(508,961)	$ (508,961)
Ending Balance at Jul. 31, 2020	$ 510	$ 49,498	55,493,492	(57,289,357)	(1,745,857)
Ending Balance, shares at Jul. 31, 2020	51,000,000	4,949,822,059
Beginning Balance at Apr. 30, 2020		$ 47,806	55,070,983	(56,964,137)	(1,845,348)
Beginning Balance, shares at Apr. 30, 2020		4,780,603,012
Issuance of common stock and warrants in private placement	$ 510		48,552		49,062
Issuance of common stock and warrants in private placement, shares	51,000,000
Shares issued for conversion of notes		$ 978	62,082		63,060
Shares issued for conversion of notes, shares		97,790,476
Resolution of derivative liabilities due to debt conversions and untainted warrants			262,589		262,589
Shares issued for services		$ 714	49,286		50,000
Shares issued for services, shares		71,428,571
Net loss				(325,220)	(325,220)
Ending Balance at Jul. 31, 2020	$ 510	$ 49,498	$ 55,493,492	$ (57,289,357)	$ (1,745,857)
Ending Balance, shares at Jul. 31, 2020	51,000,000	4,949,822,059

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jul. 31, 2020	Jul. 31, 2019
Cash flows from operating activities:
Net loss	$ (508,961)	$ (66,623)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	3,347	770
Amortization of debt discounts	155,364	22,322
(Gain) on settlement of accounts payable		(177,000)
Loss on change in fair value of derivative liabilities	39,631	4,462
Stock-based compensation		60,670
Common shares issued for third party services	50,000
Changes in assets and liabilities:
Prepaid expenses	(1,177)	1,232
Accounts payable and accrued expenses	86,535	(42,064)
Accounts payable to related parties		(1,213)
Accrued wages related parties		36,137
Accrued interest	11,151	10,255
Cash flows used in operating activities:	(164,110)	(151,052)
Cash flows from financing activities:
Proceeds from notes payable	62,974	10,000
Cash advance from related party	10,000
Proceeds from notes payable, related parties	55,000	22,000
Proceeds from convertible promissory notes		100,000
Proceeds from the issuance of common stock	20,599	50,000
Net cash provided by financing activities	148,573	182,000
Increase (decrease) in cash and cash equivalents	(15,537)	30,948
Cash and cash equivalents, beginning of period	25,024	890
Cash and cash equivalents, end of period	9,487	31,838
Supplemental disclosure of cash flow information:
Income tax paid
Interest paid		5,961
Supplemental disclosure of non-cash items:
Settlement of accounts payable through issuance of common stock		36,000
Resolution of derivative liabilities due to debt conversions and untainted warrants	369,103	63,118
Reclass of APIC to derivative liabilities for tainted warrants	189,472
Debt discounts due to derivative liabilities	140,000
Common stock issued for conversion of debt and interest	169,860	21,714
Class A Common Stock issued for conversion of related party advances and notes payable	49,062
Expenses paid by related party on behalf of the Company	$ 89,958

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jul. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	NOTE 1 – Basis of Presentation The consolidated financial statements included herein have been prepared by Liberty Star Uranium & Metals Corp. (the “Company”, “we”, “our”) without audit, pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and should be read in conjunction with our annual report on Form 10-K for the year ended January 31, 2020 as filed with the SEC under the Securities and Exchange Act of 1934 (the “Exchange Act”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, as permitted by the SEC, although we believe the disclosures which are made are adequate to make the information presented not misleading. The consolidated financial statements reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position at July 31, 2020 and the results of our operations and cash flows for the periods presented. Interim results are subject to significant seasonal variations and the results of operations for the six months ended July 31, 2020 are not necessarily indicative of the results to be expected for the full year.

Going Concern

Going Concern	6 Months Ended
	Jul. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 2 – Going concern The Company has incurred losses from operations and requires additional funds for further exploratory activity and to maintain its claims prior to attaining a revenue generating status. There are no assurances that a commercially viable mineral deposit exists on any of our properties. In addition, the Company may not find sufficient ore reserves to be commercially mined. As such, there is substantial doubt about the Company’s ability to continue as a going concern. Management is working to secure additional funds through the exercise of stock warrants already outstanding, equity financings, debt financings or joint venture agreements. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3 – Summary of Significant Accounting Policies Fair Value ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services. Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort. Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liability. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liability, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liability are reported in other income (expense) as gain (loss) on change in fair value of derivative liability.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jul. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 4 – Related party transactions Our CEO, Brett Gross, was elected as President and Chief Executive Officer on December 7, 2018 and received no compensation for these services during the six months ended July 31, 2020. At July 31 and January 31, 2020, we had accounts payable to JABA (controlled by James Briscoe) of $34,798, which is reflected as accounts payable to related parties on the accompanying consolidated balance sheets. At July 31 and January 31, 2020, we had a balance of $13,325 due to the spouse of James Briscoe. At July 31 and January 31, 2020, we had an aggregate balance due of approximately $167,000 on credit cards guaranteed by James Briscoe reflected in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. At July 31 and January 31, 2020, we had a balance of accrued unpaid wages of $759,949 to James Briscoe, our former Chairman of the Board, CEO, CFO and President. Additionally, we had a balance of accrued unpaid wages of $15,625 to a former President and $36,137 to Patricia Madaris, CFO. On January 11, 2019, we discontinued renting an office month-to-month from James Briscoe, a director who resigned on September 23, 2019. An amount of $2,610 of rent was unpaid as of July 31 and January 31, 2020. During the six months ended July 31, 2020, our CEO, Brett Gross, made various payments on behalf of the Company totaling $89,958, and advanced the Company $10,000 in cash, all of which are reflected as advances from related party on the accompanying consolidated balance sheet. The total advances were $177,058 and $101,631 as of July 31 and January 31, 2020, respectively, bear no interest and have no specified repayment date. On June 30, 2020 the Company issued 25,500,000 shares of its “Class A Common Stock” to our CEO for repayment of $24,531 of advances ($0.000962 per share). During the six months ended July 31, 2020, the Company received proceeds of $55,000 from a director under a promissory note extended with interest at 10%. Total maturities of principal and accrued interest under all notes to two directors are $194,320 due October 31, 2020. Additionally, the Company has a note payable of $10,000 from James Briscoe, under a promissory note dated September 17, 2018, which matured and became past due at September 17, 2019 with interest at 10%. As of July 31 and January 31, 2020, the total balance of all related party notes was $206,188 and $166,560, respectively, which includes accrued interest of $23,987 and $14,828, respectively. On June 30, 2020 the Company issued 25,500,000 shares of its “Class A Common Stock” to one of the directors for repayment of $24,531 of their promissory note ($0.000962 per share).

Stock Options

Stock Options	6 Months Ended
	Jul. 31, 2020
Share-based Payment Arrangement [Abstract]
Stock Options	NOTE 5 – Stock options Qualified and Non-qualified incentive stock options outstanding at July 31, 2020 are as follows: Weighted Number of exercise options price per share Outstanding, January 31, 2020 88,500,000 $ 0.012 Granted - - Expired - - Exercised - - Outstanding, July 31, 2020 88,500,000 $ 0.012 Exercisable, July 31, 2020 88,500,000 $ 0.012 These options had a weighted average remaining life of 6.70 years and an aggregate intrinsic value of $0 as of July 31, 2020. During the six months ended July 31, 2020 and 2019, we recognized $0 and $60,670, respectively, of compensation expense related to stock options.

Warrants

Warrants	6 Months Ended
	Jul. 31, 2020
Warrants and Rights Note Disclosure [Abstract]
Warrants	NOTE 6 – Warrants As of July 31, 2020, there were 200,082,809 whole share purchase warrants outstanding and exercisable. The warrants have a weighted average remaining life of 1.7 years and a weighted average exercise price of $0.004 per whole warrant for one common share. The warrants had an aggregate intrinsic value of $5,950 as of July 31, 2020. Stock warrants outstanding at July 31, 2020 are as follows: Number of Weighted whole share average purchase exercise Outstanding, January 31, 2020 186,582,809 $ 0.005 Issued 13,500,000 0.001 Expired — — Exercised — — Outstanding, July 31, 2020 200,082,809 $ 0.004 Exercisable, July 31, 2020 200,082,809 $ 0.004 During the six months ended July 31, 2020, the Company issued 13,500,000 warrants to investors as part of their purchase of common stock. The warrants have a three-year term and are exercisable at any time at exercise prices ranging from $0.0008 to $0.0011. Effective May 27, 2020, the Company extended the due date of all warrants expiring during the 12 months ending December 31, 2020, totaling 22,532,348 warrants, for an additional three years, including 4,875,000 warrants previously set to expire in January 2020. There was no expense related to the extension of these warrants since these were held by investors.

Derivative Liabilities

Derivative Liabilities	6 Months Ended
	Jul. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	NOTE 7 – Derivative Liabilities The embedded conversion feature in the convertible debt instruments that the Company issued (See Note 8), that became convertible during the six months ended July 31, 2020, qualified it as a derivative instrument since the number of shares issuable under the note is indeterminate based on guidance in FASB ASC 815, Derivatives and Hedging. These convertible notes tainted all other equity linked instruments including outstanding warrants and fixed rate convertible debt on the date that the instrument became convertible. The valuation of the derivative liability of the warrants was determined through the use of a Monte Carlo options model that values the liability of the warrants based on a risk-neutral valuation where the price of the option is its discounted expected value. The technique applied generates a large number of possible (but random) price paths for the underlying common stock via simulation, and then calculates the associated exercise value (i.e. “payoff”) of the option for each path. These payoffs are then averaged and discounted to a current valuation date resulting in the fair value of the option. The valuation of the derivative liability attached to the convertible debt was arrived at through the use of a Monte Carlo model that values the derivative liability within the notes. The technique applied generates a large number of possible (but random) price paths for the underlying (or underlyings) via simulation, and then calculates the associated payment value (cash, stock, or warrants) of the derivative features. The price of the underlying common stock is modeled such that it follows a geometric Brownian motion with constant drift, and elastic volatility (increasing as stock price decreases). The stock price is determined by a random sampling from a normal distribution. Since the underlying random process is the same, for enough price paths, the value of the derivative is derived from path dependent scenarios and outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion features with the reset provisions, the call/redemption/prepayment options, and the default provisions. Based on these features, there are six primary events that can occur; payments are made in cash; payments are made with stock; the note holder converts upon receiving a redemption notice; the note holder converts the note; the issuer redeems the note; or the Company defaults on the note. The model simulates the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, conversion price, etc.). Probabilities were assigned to each variable such as redemption likelihood, default likelihood, and timing and pricing of reset events over the remaining term of the notes based on management projections. This led to a cash flow simulation over the life of the note. A discounted cash flow for each simulation was completed, and it was compared to the discounted cash flow of the note without the embedded features, thus determining a value for the derivative liability. Key inputs and assumptions used to value the convertible note when it became convertible and upon settlement, and warrants upon tainting, were as follows: ● The stock projections are based on the historical volatilities for each date. These volatilities were in the 193.9% to 257.8% range . The stock price projection was modeled such that it follows a geometric Brownian motion with constant drift and a constant volatility, starting with the market stock price at each valuation date; ● An event of default would not occur during the remaining term of the note; ● Conversion of the notes to stock would be completed monthly after any holding period and would be limited based on: 5% of the last 6 months average trading volume and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month. ● The effective discount was determined based on the historical trading history of the Company based on the specific pricing mechanism in each note; ● The Company would not have funds available to redeem the notes during the remaining term of the convertible notes; ● Discount rates were based on risk free rates in effect based on the remaining term and date of each valuation and instrument. ● The Holder would exercise the warrant at maturity if the stock price was above the exercise price; ● The Holder would exercise the warrant after any holding period prior to maturity at target prices starting at 2 times the exercise price for the Warrants or higher subject to monthly limits of: 5% of the last 6 months average trading volume increasing by 1% per month and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month. Using the results from the model, the Company recorded a derivative liability during the six months ended July 31, 2020 of $189,472 for newly granted and existing warrants (see Note 6) that were tainted and a derivative liability of $204,343 for the fair value of the convertible feature included in the Company’s convertible debt instruments. The derivative liability recorded for the convertible feature created a “day 1” derivative loss of $64,343 and a debt discount of $140,000 that was amortized over the remaining term of the note using the effective interest rate method. Interest expense related to the amortization of this debt discount for the six months ended July 31, 2020, was $140,000. The remaining unamortized debt discount related to the derivative liability was $0 as of July 31, 2020. During the six months ended July 31, 2020, the Company recorded a reclassification from derivative liability to equity of $189,518 for warrants becoming untainted and $179,585 due to the conversions of a portion of the Company’s convertible notes. The Company also recorded the change in the fair value of the derivative liability as a loss of $39,631 to reflect the value of the derivative liability for warrants and convertible notes as of July 31, 2020. During the six months ended July 31, 2019, the Company recorded a reclassification from derivative liability to equity of $40,905 for warrants becoming untainted and $22,213 due to the conversions of a portion of the Company’s convertible notes. The Company recorded the change in the fair value of the derivative liability as a loss of $4,462 to reflect the value of the derivative liability for warrants and convertible notes as of July 31, 2019. The Company did not have a derivative liability as of July 31, 2020 and 2019 since outstanding convertible notes were fully converted during the period and consequently, the outstanding warrants were no longer tainted. The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liability: Six months ended July 31, 2020 2019 Beginning balance $ - $ 58,656 Total loss 39,631 4,462 Settlements (369,103 ) (63,118 ) Additions recognized as debt discount 140,000 - Additions due to tainted warrants 189,472 - Ending balance $ - $ - Change in unrealized loss included in earnings relating to derivatives as of July 31, 2020 and 2019 $ 39,631 $ 4,462

Convertible Promissory Notes an

Convertible Promissory Notes and Notes Payable	6 Months Ended
	Jul. 31, 2020
Debt Disclosure [Abstract]
Convertible Promissory Notes and Notes Payable	NOTE 8 – Convertible promissory notes and notes payable Following is a summary of convertible promissory notes: July 31, 2020 January 31, 2020 8% convertible note payable issued August 2019, due May 2020 $ - $ 79,886 8% convertible note payable issued October 2019, due August 2020 - 48,347 8% convertible note payable issued January 2020, due November 2020 - 39,635 - 167,868 Less debt discount - (15,364 ) Less current portion of convertible notes - (152,504 ) Long-term convertible notes payable $ - $ - On August 15, 2019, we received net proceeds of $67,000 from the issuance of a convertible note dated August 13, 2019 (the “August 2019 Note”). The note bears interest at 8%, includes OID of $10,000, matures on May 30, 2020, and is convertible after 180 days into shares of the Company’s common stock at a price of 75% of the average of the lowest 5 weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. During the six months ended July 31, 2020, the noteholder converted a total of $79,800 of the note in for 136,375,071 shares of the Company’s common stock, leaving a balance of $0 as of July 31, 2020. On October 25, 2019, we received net proceeds of $40,000 from the issuance of a convertible note dated October 22, 2019 (the “October 2019 Note”). The note bears interest at 8%, includes OID of $7,300, matures on August 15, 2020, and is convertible after 180 days into shares of the Company’s common stock at a price of 75% of the average of the lowest 5 weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. During the six months ended July 31, 2020, the noteholder converted a total of $49,020 of the note in for 107,798,581 shares of the Company’s common stock, leaving a balance of $0 as of July 31, 2020. On January 30, 2020, we received net proceeds of $33,000 from the issuance of a convertible note dated January 27, 2020 (the “January 2020 Note”). The note bears interest at 8%, includes OID of $3,600 and legal fees of $3,000, matures on November 15, 2020, and is convertible after 180 days into shares of the Company’s common stock at a price of 75% of the average of the lowest 5 weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. During the six months ended July 31, 2020, the noteholder converted a total of $41,040 of the note in for 48,857,143 shares of the Company’s common stock, leaving a balance of $0 as of July 31, 2020. During the six months ended July 31, 2020 and 2019, the Company recorded debt discounts of $140,000 and $0, respectively, due to the derivative liabilities, and original issue debt discounts of $0 and $6,000, respectively, due to the convertible notes. The Company recorded amortization of these discounts of $155,364 and $22,322 for the six months ended July 31, 2020 and 2019, respectively. Notes Payable On May 5, 2020, the Company received loan proceeds of $30,387 under the SBA’s Paycheck Protection Program (“PPP”). The PPP loan, dated May 5, 2020, bears interest at 1% and is due in 18 monthly installments of $1,710 beginning December 1, 2020. Under the loan terms, the Company may apply (and plans to apply) for forgiveness of the loan. On June 22, 2020, the Company received loan proceeds of $32,300 (net of $100 loan fee) under the SBA’s Economic Injury Disaster Loan program (“EIDL”). The EIDL loan, dated June 16, 2020, bears interest at 3.75%, has a 30-year term, is secured by substantially all assets of the Company, and is due in monthly installments of $158 beginning June 16, 2021. The balance of these two notes total $62,974, including interest of $187, and is included in long-term debt as of July 31, 2020. On May 5, 2020, the Company received grant proceeds of $3,000 under the EIDL program which is reflected as a credit to salaries and benefits expense for the six months ended July 31, 2020.

Stockholders' Deficit

Stockholders' Deficit	6 Months Ended
	Jul. 31, 2020
Equity [Abstract]
Stockholders' Deficit	NOTE 9 – Stockholders’ deficit Class A Common Stock On June 22, 2020, the Company filed a Certificate of Designation with the Secretary of State of Nevada to establish the terms of the Company’s Class A Common Stock (the “Class A Shares”), par value $0.00001 per share, 100,000,000 shares authorized. The terms of the Class A Shares include 200-1 voting rights in addition to the rights held by common stock holders. Only persons who are current members of the Company’s Board of Directors may own or hold Class A Shares. On June 30, 2020, the Company entered into an agreement to issue a total of 51,000,000 shares of its Class A Shares to two directors of the Company. The aggregate consideration paid for the Class A Shares was $49,062 ($0.000962 per share). The consideration was paid by offsetting the purchase price against Company advances and notes held by the two directors (see Note 4). Common Stock Our undesignated common shares are all of the same class, are voting and entitle stockholders to receive dividends as defined. Upon liquidation or wind-up, stockholders are entitled to participate equally with respect to any distribution of net assets or any dividends that may be declared. During the six months ended July 31, 2020, the Company issued a total of 293,030,795 shares of our common stock for conversions of $169,860 of convertible notes payable and accrued interest at an exercise prices ranging from of $0.00045 to $0.00084. During the six months ended July 31, 2020, the Company issued a total of 27,000,000 shares of its common stock and 13,500,000 warrants to two investors for proceeds of $20,599, or $0.0006 to $0.0008 per share. The warrants have a three-year term and are exercisable at any time at an exercise price of $0.0008 to $0.0011 per share. During the six months ended July 31, 2020, the Company issued 71,428,571 shares of its common stock to a consultant for services at an aggregate price of $50,000, or $0.0007 per share.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 10 – Commitments and contingencies Legal Matter On August 22, 2019 (and amended on December 23, 2019), the Company filed a complaint with the Superior Court of Arizona (Case No. C20194139), demanding the titles and possession of certain vehicles and equipment of the Company from our former CEO, as well as seeking recovery of damages from the former CEO in an amount of not less than $50,000. None of the vehicles and equipment, individually or in total, have any material net book value (being fully depreciated) as of July 31 or January 31, 2020. The matter is ongoing as of the date of this filing. On February 18, 2020, our former CEO and his spouse ​(the “Counterclaimants”) filed a First Amended Answer: First Amended Complaint and Counterclaim with the Superior Court of Arizona seeking dismissal of the Company’s complaint and reimbursement of Counterclaimants’ attorney fees incurred related to the matter. Additionally, the counterclaim alleges breach of contract by the Company and requests reimbursement of amounts loaned to the Company by our former CEO and his spouse, along with reimbursement of attorney fees. The Company ​believes these counterclaims are without merit and is aggressively defending them, and believes no unfavorable outcome or material effect on our consolidated financial statements will result.

Subsequent Events

Subsequent Events	6 Months Ended
	Jul. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 11 – Subsequent events On August 13, 2020 , the Company formed Red Rock Mines, LLC, an Arizona corporation, as a wholly-owned subsidiary of Hay Mountain Holdings, LLC.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2020
Accounting Policies [Abstract]
Fair Value	Fair Value ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services. Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort. Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liability. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liability, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liability are reported in other income (expense) as gain (loss) on change in fair value of derivative liability.

Stock Options (Tables)

Stock Options (Tables)	6 Months Ended
	Jul. 31, 2020
Share-based Payment Arrangement [Abstract]
Schedule of Stock Options Activity	Qualified and Non-qualified incentive stock options outstanding at July 31, 2020 are as follows: Weighted Number of exercise options price per share Outstanding, January 31, 2020 88,500,000 $ 0.012 Granted - - Expired - - Exercised - - Outstanding, July 31, 2020 88,500,000 $ 0.012 Exercisable, July 31, 2020 88,500,000 $ 0.012

Warrants (Tables)

Warrants (Tables)	6 Months Ended
	Jul. 31, 2020
Warrants and Rights Note Disclosure [Abstract]
Schedule of Stock Warrants Outstanding	Stock warrants outstanding at July 31, 2020 are as follows: Number of Weighted whole share average purchase exercise Outstanding, January 31, 2020 186,582,809 $ 0.005 Issued 13,500,000 0.001 Expired — — Exercised — — Outstanding, July 31, 2020 200,082,809 $ 0.004 Exercisable, July 31, 2020 200,082,809 $ 0.004

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	6 Months Ended
	Jul. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Changes in Fair Value of Derivative Liabilities	The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liability: Six months ended July 31, 2020 2019 Beginning balance $ - $ 58,656 Total loss 39,631 4,462 Settlements (369,103 ) (63,118 ) Additions recognized as debt discount 140,000 - Additions due to tainted warrants 189,472 - Ending balance $ - $ - Change in unrealized loss included in earnings relating to derivatives as of July 31, 2020 and 2019 $ 39,631 $ 4,462

Convertible Promissory Notes _2

Convertible Promissory Notes and Notes Payable (Tables)	6 Months Ended
	Jul. 31, 2020
Debt Disclosure [Abstract]
Summary of Convertible Promissory Notes	Following is a summary of convertible promissory notes: July 31, 2020 January 31, 2020 8% convertible note payable issued August 2019, due May 2020 $ - $ 79,886 8% convertible note payable issued October 2019, due August 2020 - 48,347 8% convertible note payable issued January 2020, due November 2020 - 39,635 - 167,868 Less debt discount - (15,364 ) Less current portion of convertible notes - (152,504 ) Long-term convertible notes payable $ - $ -

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019	Jan. 31, 2020
Related Party Transaction [Line Items]
Accrued unpaid wages			$ 811,711		$ 811,711
Advances from related party			$ 177,058		101,631
Number of common stock issued		$ 36,000		$ 36,000
Share price per share			$ 0.0007
Proceeds from promissory notes			$ 62,974	10,000
Notes payable to related party			206,188		166,560
Accrued interest			23,987		14,828
Director [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Proceeds from promissory notes			$ 55,000
Debt instrument, interest rate			10.00%
Two Directors [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Debt instrument, maturity date			Oct. 31, 2020
Two Directors [Member] | Promissory Note [Member] | October 31, 2020 [Member]
Related Party Transaction [Line Items]
Due to related party			$ 194,320
Class A Common Stock [Member]
Related Party Transaction [Line Items]
Number of common stock issued
Class A Common Stock [Member] | CEO [Member]
Related Party Transaction [Line Items]
Advances from related party	$ 24,531
Number of common stock issued	$ 25,500,000
Share price per share	$ 0.000962
Class A Common Stock [Member] | Director One [Member]
Related Party Transaction [Line Items]
Advances from related party	$ 24,531
Number of common stock issued	$ 25,500,000
Share price per share	$ 0.000962
James Briscoe [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Proceeds from promissory notes			$ 10,000
Debt instrument, interest rate			10.00%
Debt instrument, maturity date			Sep. 17, 2019
James Briscoe [Member] | Accounts Payable [Member]
Related Party Transaction [Line Items]
Due to related party			$ 34,798		34,798
James Briscoe [Member] | Accounts Payable and Accrued Liabilities [Member]
Related Party Transaction [Line Items]
Due to related party on credit cards guaranteed			167,000		167,000
Spouse of James Briscoe [Member]
Related Party Transaction [Line Items]
Due to related party			13,325		13,325
Accrued unpaid wages			759,949		759,949
Unpaid rent			2,610		2,610
Former President [Member]
Related Party Transaction [Line Items]
Accrued unpaid wages			15,625		15,625
Patricia Madaris, CFO [Member]
Related Party Transaction [Line Items]
Accrued unpaid wages			36,137		$ 36,137
Brett Gross, CFO [Member]
Related Party Transaction [Line Items]
Due to related party			89,958
Advances from related party			$ 10,000

Stock Options (Details Narrativ

Stock Options (Details Narrative) - USD ($)	6 Months Ended
	Jul. 31, 2020	Jul. 31, 2019
Share-based Payment Arrangement [Abstract]
Weighted average remaining life, stock options	6 years 8 months 12 days
Stock options, aggregate intrinsic value	$ 0
Compensation expense	$ 0	$ 60,670

Stock Options - Schedule of Sto

Stock Options - Schedule of Stock Options Activity (Details)	6 Months Ended
	Jul. 31, 2020$ / sharesshares
Share-based Payment Arrangement [Abstract]
Number of options, Outstanding | shares	88,500,000
Number of options, Granted | shares
Number of options, Expired | shares
Number of options, Exercised | shares
Number of options, Outstanding | shares	88,500,000
Number of options, Exercisable | shares	88,500,000
Weighted average exercise price per share, Outstanding | $ / shares	$ 0.012
Weighted average exercise price per share, Granted | $ / shares
Weighted average exercise price per share, Expired | $ / shares
Weighted average exercise price per share, Exercised | $ / shares
Weighted average exercise price per share, Outstanding | $ / shares	0.012
Weighted average exercise price per share, Exercisable | $ / shares	$ 0.012

Warrants (Details Narrative)

Warrants (Details Narrative) - USD ($)	6 Months Ended
	Jul. 31, 2020	May 27, 2020
Warrants [Line Items]
Share purchase warrants outstanding and exercisable	200,082,809
Warrants weighted average remaining life	1 year 8 months 12 days
Weighted average exercise price of warrant	$ 0.004
Weighted average intrinsic value for warrants outstanding	$ 5,950
Number of warrants issued	13,500,000
Warrants terms	3 years	3 years
Warrants extend, description	Effective May 27, 2020, the Company extended the due date of all warrants expiring during the 12 months ending December 31, 2020
Warrants outstanding		$ 22,532,348
Previously Set to Expire in January 2020 [Member]
Warrants [Line Items]
Warrants outstanding		$ 4,875,000
Minimum [Member]
Warrants [Line Items]
Warrant exercise price per share	$ 0.0008
Maximum [Member]
Warrants [Line Items]
Warrant exercise price per share	$ 0.0011

Warrants - Schedule of Stock Wa

Warrants - Schedule of Stock Warrants Outstanding (Details) - Warrant [Member]	6 Months Ended
	Jul. 31, 2020$ / sharesshares
Warrants [Line Items]
Number of warrants, Outstanding | shares	186,582,809
Number of warrants, Issued | shares	13,500,000
Number of warrants, Expired | shares
Number of warrants, Exercised | shares
Number of warrants, Outstanding | shares	200,082,809
Number of warrants, Exercisable | shares	200,082,809
Weighted average exercise price, Outstanding | $ / shares	$ 0.005
Weighted average exercise price, Issued | $ / shares	0.001
Weighted average exercise price, Expired | $ / shares
Weighted average exercise price, Exercised | $ / shares
Weighted average exercise price, Outstanding | $ / shares	0.004
Weighted average exercise price, Exercisable | $ / shares	$ 0.004

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative)	6 Months Ended
	Jul. 31, 2020USD ($)Integer	Jul. 31, 2019USD ($)	Jan. 31, 2020USD ($)	Apr. 30, 2019USD ($)
Unamortized debt discount	$ 0			$ 6,000
Derivative Liability [Member]
Conversion note description	Conversion of the notes to stock would be completed monthly after any holding period and would be limited based on: 5% of the last 6 months average trading volume and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month.
Percentage of exercise price for warrant, description	The Holder would exercise the warrant after any holding period prior to maturity at target prices starting at 2 times the exercise price for the Warrants or higher subject to monthly limits of: 5% of the last 6 months average trading volume increasing by 1% per month and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month.
Derivative loss	$ 64,343
Amortization of debt discount	140,000
Interest expense	140,000
Unamortized debt discount			$ 0
Reclassification of derivative liability to equity	189,518	$ 40,905
Reclassification due to conversion of convertible notes	179,585	22,213
Gain on derivative liability	39,631	$ 4,462
Derivative Liability [Member] | Convertible Debt [Member]
Derivative liabilities	204,343
Derivative Liability [Member] | Warrant [Member]
Derivative liabilities	$ 189,472
Measurement Input, Price Volatility [Member] | Minimum [Member]
Fair value assumptions, measurement input, percentages | Integer	193.9
Measurement Input, Price Volatility [Member] | Maximum [Member]
Fair value assumptions, measurement input, percentages | Integer	257.8

Derivative Liabilities - Schedu

Derivative Liabilities - Schedule of Changes in Fair Value of Derivative Liabilities (Details) - USD ($)	6 Months Ended
	Jul. 31, 2020	Jul. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Beginning balance		$ 58,656
Total loss	39,631	4,462
Settlements	(369,103)	(63,118)
Additions recognized as debt discount	140,000
Additions due to tainted warrants	189,472
Ending balance
Change in unrealized loss included in earnings relating to derivatives as of July 31, 2020 and 2019	$ 39,631	$ 4,462

Convertible Promissory Notes _3

Convertible Promissory Notes and Notes Payable (Details Narrative)	Dec. 01, 2020USD ($)	Jun. 22, 2020USD ($)	May 05, 2020USD ($)	Jan. 30, 2020USD ($)Integer	Oct. 25, 2019USD ($)Integer	Aug. 15, 2019USD ($)Integer	Jul. 31, 2020USD ($)	Jul. 31, 2019USD ($)	Jul. 31, 2020USD ($)shares	Jul. 31, 2019USD ($)	Apr. 30, 2019USD ($)
Debt Instrument [Line Items]
Net proceeds from debt										$ 100,000
Original issue discount amount							$ 0		0		$ 6,000
Legal fees							44,936	$ 1,475	95,472	1,475
Debt discounts amount									140,000	0
Amortization of debt discount									155,364	22,322
Proceeds from debt									62,974	$ 10,000
Paycheck Protection Program [Member]
Debt Instrument [Line Items]
Proceeds from loan			$ 30,387
Loan, interest rate			1.00%
Loan due number of installments			Due in 18 monthly installments
Loan installment due amount	$ 1,710
SBA's Economic Injury Disaster Loan Program [Member]
Debt Instrument [Line Items]
Proceeds from loan		$ 32,300
Loan, interest rate		3.75%
Loan installment due amount		$ 158
Loan fee		$ 100
Debt term		30 years
Loan expiration date		Jun. 16, 2021
Economic Injury Disaster Loan Program [Member]
Debt Instrument [Line Items]
Debt principal									62,974
Debt including interest									187
Proceeds from debt			$ 3,000
August 2019 Note [Member]
Debt Instrument [Line Items]
Net proceeds from debt						$ 67,000
Debt instrument interest rate						8.00%
Original issue discount amount						$ 10,000
Debt instrument, maturity date						May 30, 2020
Debt instrument convertible consecutive trading days | Integer						180
Common stock conversion price per share						75.00%
Debt instrument, convertible, threshold trading days | Integer						10
Debt instrument conversion, amount									$ 79,800
Debt conversion on convertible shares | shares									136,375,071
Principal and interest total amount							0		$ 0
October 2019 [Member]
Debt Instrument [Line Items]
Net proceeds from debt					$ 40,000
Debt instrument interest rate					8.00%
Original issue discount amount					$ 7,300
Debt instrument, maturity date					Aug. 15, 2020
Debt instrument convertible consecutive trading days | Integer					180
Common stock conversion price per share					75.00%
Debt instrument, convertible, threshold trading days | Integer					10
Debt instrument conversion, amount									$ 49,020
Debt conversion on convertible shares | shares									107,798,581
Principal and interest total amount							0		$ 0
January 2020 Note [Member]
Debt Instrument [Line Items]
Net proceeds from debt				$ 33,000
Debt instrument interest rate				8.00%
Original issue discount amount				$ 3,600
Debt instrument, maturity date				Nov. 15, 2020
Debt instrument convertible consecutive trading days | Integer				180
Common stock conversion price per share				75.00%
Debt instrument, convertible, threshold trading days | Integer				10
Debt instrument conversion, amount									$ 41,040
Debt conversion on convertible shares | shares									48,857,143
Principal and interest total amount							$ 0		$ 0
Legal fees				$ 3,000

Convertible Promissory Notes _4

Convertible Promissory Notes and Notes Payable - Summary of Convertible Promissory Notes (Details) - USD ($)	Jul. 31, 2020	Jan. 31, 2020
Debt Instrument [Line Items]
Convertible note payable		$ 167,868
Less debt discount		(15,364)
Less current portion of convertible notes		(152,504)
Long-term convertible notes payable
Convertible Debt One [Member]
Debt Instrument [Line Items]
Convertible note payable		79,886
Convertible Debt Two [Member]
Debt Instrument [Line Items]
Convertible note payable		48,347
Convertible Debt Three [Member]
Debt Instrument [Line Items]
Convertible note payable		$ 39,635

Convertible Promissory Notes _5

Convertible Promissory Notes and Notes Payable - Summary of Convertible Promissory Notes (Details) (Parenthetical)	6 Months Ended	12 Months Ended
	Jul. 31, 2020	Jan. 31, 2020
Convertible Debt One [Member]
Percentage of convertible notes	8.00%	8.00%
Debt issuance date	Aug. 31, 2019	Aug. 31, 2019
Due date	May 31, 2020	May 31, 2020
Convertible Debt Two [Member]
Percentage of convertible notes	8.00%	8.00%
Debt issuance date	Oct. 31, 2019	Oct. 31, 2019
Due date	Aug. 31, 2020	Aug. 31, 2020
Convertible Debt Three [Member]
Percentage of convertible notes	8.00%	8.00%
Debt issuance date	Jan. 31, 2020	Jan. 31, 2020
Due date	Nov. 30, 2020	Nov. 30, 2020

Stockholders' Deficit (Details

Stockholders' Deficit (Details Narrative) - USD ($)	Jun. 30, 2020	Jun. 22, 2020	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019	May 27, 2020	Jan. 31, 2020
Common stock, par value			$ 0.00001		$ 0.00001			$ 0.00001
Common stock, shares authorized			6,150,000,000		6,150,000,000			6,250,000,000
Shares issued, exercise price per share			$ 0.0007		$ 0.0007
Issuance of warrants, shares			13,500,000		13,500,000
Warrants term			3 years		3 years		3 years
Shares issued for services			$ 50,000		$ 50,000
Shares issued for services, shares					71,428,571
Minimum [Member]
Shares issued, exercise price per share			$ 0.00045		$ 0.00045
Warrants exercise price, per share			0.0008		0.0008
Maximum [Member]
Shares issued, exercise price per share			0.00084		0.00084
Warrants exercise price, per share			$ 0.0011		$ 0.0011
Common Stock [Member]
Number of shares issued for conversion, shares					293,030,795
Number of shares issued for conversion, amount					$ 169,860
Number of shares issued during period, new issues, shares				30,000,000		30,000,000
Shares issued for services			$ 714		$ 714
Shares issued for services, shares			71,428,571		71,428,571
Two Investors [Member]
Number of shares issued during period, new issues, shares					27,000,000
Issuance of warrants, shares			13,500,000		13,500,000
Proceeds from warrants					$ 20,599
Warrants term			3 years		3 years
Two Investors [Member] | Minimum [Member]
Warrants exercise price, per share			$ 0.0006		$ 0.0006
Two Investors [Member] | Maximum [Member]
Warrants exercise price, per share			0.0008		0.0008
Class A Common Stock [Member]
Common stock, par value		$ 0.00001	$ .00001		$ .00001			$ .00001
Common stock, shares authorized		100,000,000	100,000,000		100,000,000			0
Voting rights		The terms of the Class A Shares include 200-1 voting rights in addition to the rights held by common stock holders.
Class A Common Stock [Member] | Two Directors [Member]
Number of shares issued for conversion, shares	51,000,000
Number of shares issued for conversion, amount	$ 49,062
Shares issued, exercise price per share	$ 0.000962

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)	Aug. 22, 2019USD ($)
Former Chief Executive Officer [Member]
Loss contingency damages sought value	$ 50,000